Sponsor

This article addresses the most frequently asked questions about Real Ear-to-Coupler Difference (RECD), with a focus on adult hearing aid fittings. The answers are provided by Dr. Sherman Lord, Au.D., the National Clinical Trainer for e3 Diagnostics. Please note that the discussion of RECD in this article may not apply to all hearing aid verification systems. For specific information regarding

This article discusses the Audiology Crisis and the GSI AMTAS as one potential solution through questions answered by Tony Lombardo, Clinical Application Specialist, and Laura Prigge, Manager of Clinical Education and Training at Grason-Stadler.  Q1: What is the audiology crisis, and what are its primary causes? Prigge: The audiology crisis refers to the growing gap between the increasing demand for

Audioscan recently introduced a unique over-the-counter / direct-to-consumer (OTC/DTC) device verification test suite for their Verifit2 system. Dr. John Pumford, Au.D., Director of Audiology, Education, and Clinical Research, answers key questions about this innovative tool and offers his expert perspective on the future of hearing care. What is the Audioscan OTC/ DTC test suite for Verifit2? Great question! The Audioscan

A Comprehensive Review and Prices by Jeremy Hillpot As a hearing aid company, TruHearing alleviates some of the cost barriers that deter hearing loss patients from getting the treatment they need. However, TruHearing is not a hearing aid manufacturer. It’s a managed care provider that works with insurance companies and hearing aid manufacturers. With an extensive range of discounted hearing

Human hearing is a fascinating construct. It perceives acoustic signals and forwards them immediately to the brain for processing—it is even able to extract individual sound sources from a mixture of competing ambient noise.  The ability to extract individual sound sources from a mixture of competing ambient noise is known as the “cocktail party effect”, is also called selective hearing:

In the evolving landscape of healthcare, patient engagement has emerged as a pivotal element in delivering effective care, especially within specialized fields like audiology.  Audiologists face unique challenges, such as dealing with high no-show rates for first-time patients and the critical task of encouraging hearing aid adoption among those who need them. Additionally, many patients, when referred to audiologists for

If it’s not broke, don’t fix it. In the daily hustle and bustle of a hearing care practice, it’s sometimes hard to find time to consider upgrading to new and better software. Especially when your Noah installation works just fine. Noah ES is a cloud-based version of the Noah platform. With Noah ES, upgrading now can end up saving you

This article explores the new Audible Contrast Threshold Test (ACT™) through a series of 10 questions answered by Ashley Hughes, Au.D., Clinical Applications Specialist at Interacoustics. Discover what ACT™ is and learn how to seamlessly integrate it into your clinical practice.  1. Could you provide a brief explanation of the Audible Contrast Threshold Test (ACT™)? Hughes: ACT™ is a nonlinguistic test, meaning

Many believe a clinically valid audiometric test must occur in a sound booth. This rationale is based on the assumption that only a sound booth can eliminate background noise and possible distractions that may lead to inaccurate test results. However, recent advances in audiometric technology are enabling a shift to testing outside of the booth. This shift is being widely

Hearing loss can affect anyone. The 2021 World Report on Hearing, published by the World Health Organization (WHO), found that there are over 1.5 billion people that live with some level of hearing loss. Even more concerning is that this figure is predicted to grow to an estimated 2.5 billion by 2050. This forecast is particularly alarming because most people